BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,435 | -14.8% | 38,014 | +2.8% | 0.06% | -10.4% |
| Q2 2023 | $1,684 | +27.1% | 36,966 | +13.2% | 0.07% | +17.5% |
| Q1 2023 | $1,325 | -22.5% | 32,658 | -2.6% | 0.06% | -26.9% |
| Q4 2022 | $1,709 | -99.9% | 33,529 | -0.4% | 0.08% | -14.3% |
| Q3 2022 | $1,812,000 | -15.8% | 33,649 | +0.4% | 0.09% | -9.9% |
| Q2 2022 | $2,153,000 | -17.1% | 33,524 | +0.1% | 0.10% | -2.9% |
| Q1 2022 | $2,596,000 | -9.8% | 33,478 | -0.2% | 0.10% | -7.1% |
| Q4 2021 | $2,879,000 | -1.6% | 33,544 | -7.8% | 0.11% | -8.9% |
| Q3 2021 | $2,927,000 | -3.5% | 36,393 | -3.4% | 0.12% | -3.1% |
| Q2 2021 | $3,032,000 | -6.5% | 37,662 | -2.0% | 0.13% | -11.8% |
| Q1 2021 | $3,242,000 | +4.1% | 38,438 | -1.0% | 0.14% | -2.7% |
| Q4 2020 | $3,114,000 | +1.7% | 38,812 | +2.0% | 0.15% | -10.3% |
| Q3 2020 | $3,061,000 | -8.2% | 38,068 | -1.7% | 0.16% | -14.9% |
| Q2 2020 | $3,334,000 | +5.2% | 38,727 | -0.8% | 0.19% | -12.6% |
| Q1 2020 | $3,169,000 | -7.4% | 39,030 | -4.7% | 0.22% | +22.0% |
| Q4 2019 | $3,423,000 | -3.9% | 40,939 | +0.5% | 0.18% | -10.3% |
| Q3 2019 | $3,562,000 | +4.9% | 40,727 | -1.8% | 0.20% | +4.1% |
| Q2 2019 | $3,396,000 | +0.1% | 41,463 | -0.7% | 0.20% | -3.5% |
| Q1 2019 | $3,394,000 | +19.5% | 41,743 | -3.2% | 0.20% | +6.3% |
| Q4 2018 | $2,839,000 | -14.7% | 43,138 | -0.1% | 0.19% | -0.5% |
| Q3 2018 | $3,329,000 | +0.6% | 43,178 | -3.6% | 0.19% | -5.9% |
| Q2 2018 | $3,308,000 | +8.9% | 44,797 | -4.1% | 0.20% | +7.4% |
| Q1 2018 | $3,038,000 | -1.6% | 46,716 | -2.1% | 0.19% | +1.6% |
| Q4 2017 | $3,086,000 | +2.1% | 47,734 | -0.9% | 0.19% | -4.6% |
| Q3 2017 | $3,024,000 | +0.3% | 48,191 | -3.3% | 0.20% | -3.9% |
| Q2 2017 | $3,016,000 | +12.0% | 49,816 | -4.1% | 0.20% | +9.7% |
| Q1 2017 | $2,694,000 | +4.6% | 51,941 | -10.6% | 0.18% | +1.6% |
| Q4 2016 | $2,575,000 | -11.3% | 58,068 | -4.8% | 0.18% | -15.0% |
| Q3 2016 | $2,904,000 | +4.3% | 61,005 | -0.9% | 0.21% | +1.9% |
| Q2 2016 | $2,783,000 | -1.4% | 61,550 | -10.4% | 0.21% | -3.2% |
| Q1 2016 | $2,823,000 | +6.4% | 68,714 | -1.2% | 0.22% | +3.3% |
| Q4 2015 | $2,652,000 | +15.7% | 69,527 | -0.4% | 0.21% | +10.5% |
| Q3 2015 | $2,293,000 | -56.2% | 69,812 | -6.8% | 0.19% | -52.7% |
| Q2 2015 | $5,239,000 | +10.8% | 74,912 | +8.5% | 0.40% | +10.1% |
| Q1 2015 | $4,728,000 | +0.9% | 69,021 | +8.0% | 0.36% | +0.3% |
| Q4 2014 | $4,685,000 | +4.0% | 63,921 | +1.9% | 0.36% | +0.6% |
| Q3 2014 | $4,504,000 | +1.0% | 62,751 | +1.7% | 0.36% | +0.6% |
| Q2 2014 | $4,461,000 | -1.3% | 61,698 | +0.4% | 0.36% | -5.5% |
| Q1 2014 | $4,520,000 | +7.3% | 61,425 | +1.4% | 0.38% | +5.0% |
| Q4 2013 | $4,213,000 | +12.9% | 60,582 | +6.7% | 0.36% | +3.1% |
| Q3 2013 | $3,731,000 | -0.3% | 56,795 | +5.1% | 0.35% | -4.6% |
| Q2 2013 | $3,742,000 | – | 54,014 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |